UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037000
Receipt number R000041894
Scientific Title Limited Surgery for T1 or T2 lower rectal Cancer with neoadjuvant chemoradiotherapy
Date of disclosure of the study information 2019/06/10
Last modified on 2019/06/07 20:13:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Limited Surgery for T1 or T2 lower rectal Cancer with neoadjuvant chemoradiotherapy

Acronym

Limited Surgery for T1 or T2 lower rectal Cancer with neoadjuvant chemoradiotherapy

Scientific Title

Limited Surgery for T1 or T2 lower rectal Cancer with neoadjuvant chemoradiotherapy

Scientific Title:Acronym

Limited Surgery for T1 or T2 lower rectal Cancer with neoadjuvant chemoradiotherapy

Region

Japan


Condition

Condition

Rectal cancer

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate safety and efficacy of combination therapy of limited Surgery with neoadjuvant chemoradiotherapy for T1 or T2 lower rectal cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Pathological complete response rate

Key secondary outcomes

Relapse-free survival
Disease-free survival
Overall survival
Local relapse-free survival
Adverse events
Anal sphincter preservation
Anal function


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Xeloda was given orally after breakfast and dinner on Days 1 to 5, 8 to 12, 22 to 26, and 29 to 33.
Radiotherapy was administered in fractions of 1.8 Gy/d, given 5 days per week for 5 weeks. The total dose of radiation was 45 Gy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Main part of the tumor is located in P-Rb.
2) Previously untreated lower rectal cancer with preoperative diagnosis of T1/2 and N0 and M0.
3) Tumor diameter=< 30mm.
4) Well differentiated adenocarcinoma or Moderately differentiated adenocarcinoma.
5) No prior therapy expect the operation.
6) No severe complications
7) Age >= 20 years
8) Performance status (ECOG) of 0-1
9) Capability of oral intake
10) Patients who have satisfied the following the clinical test values within two weeks before the registration.
i. WBC: 3,500-12,000 /mm3
ii. Neutrophile >= 1,500/mm3
iii. Platelet > = 100,000/mm3
iv. Hemoglobin > = 9.0g/dL
v. Total bilirubin =< 2.0 mg/dL
vi. AST =< 100IU/L
vii. ALT =< 100IU/L
viii. Ccr >= 30 ml/min
11) Written informed consent.

Key exclusion criteria

1) Active synchronous or metachronous malignancy carcinoma in situ.
2) Non-treated radiotherapy
3) Medical history of severe anaphylaxis or allergia to any drug.
4) Severe diarrhea.
5) Undergoing treatment with Tegafur, Gimeracil, Oteracil Potassium.
6) Undergoing treatment with Warfarin Potassium, Phenytoin, Trifluridine, Tipiracil Hydrochloride.
7) Severe complication.
8) Pregnant or lactating woman at any time during study. Men of the fertility hope.
9) Severe mental disorder.
10) Patients judged inappropriate for the study by their physicians.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hasegawa
Middle name
Last name Junichi

Organization

Osaka Rosai Hospital

Division name

Department of Surgery

Zip code

591-8025

Address

1179-3 Nagasonecho, Kita-ku, Sakai 591-8025, Japan

TEL

072-252-3561

Email

j-hasegawa@osakah.johas.go.jp


Public contact

Name of contact person

1st name Sueda
Middle name
Last name Toshinori

Organization

Osaka Rosai Hospital

Division name

Department of Surgery

Zip code

591-8025

Address

1179-3 Nagasonecho, Kita-ku, Sakai 591-8025, Japan

TEL

072-252-3561

Homepage URL


Email

tsueda@osakah.johas.go.jp


Sponsor or person

Institute

Osaka Rosai Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Rosai Hospital

Address

1179-3 Nagasonecho, Kita-ku, Sakai 591-8025, Japan

Tel

072-252-3561

Email

tsueda@osakah.johas.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 03 Month 05 Day

Date of IRB

2018 Year 03 Month 05 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 07 Day

Last modified on

2019 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041894